Skip to content

Crime & JusticeBreaking

Two Indian nationals indicted over alleged counterfeit Ozempic smuggling scheme

By

Coverage spectrum

Covered by 4 outlets across the spectrum.

4 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias

The Justice Department has indicted two Indian nationals, Swapnadip Roy, 33, and Vicky Ramancha, 37, on charges connected to an alleged scheme to smuggle counterfeit Ozempic into the United States from unauthorized sources in China. According to court filings, the scheme began around July 2023 and continued even after the FDA seized some counterfeit product and issued a public warning in December 2023. Both men are charged with one count of conspiracy to commit smuggling and defraud the U.S., three counts of smuggling, and two counts of selling and holding counterfeit drugs for sale, carrying a maximum penalty of 71 years in prison each if convicted. Roy was extradited from Italy and made his initial court appearance Tuesday; Ramancha remains at large.

Headline and summary written by Mantle’s AI from the coverage below, under published rules. How this works

What happened

Key points

Each point shows who reports it, from Far Left to Far Right.

  1. Swapnadip Roy, 33, and Vicky Ramancha, 37, were indicted in the Middle District of Florida on smuggling and conspiracy charges.

    Reported byLeftCenterRight

  2. The men allegedly smuggled counterfeit Ozempic from unauthorized sources in China into the U.S.

    Reported byLeftCenterRight

  3. Roy was extradited from Italy and made his initial court appearance on Tuesday; Ramancha remains at large.

    Reported byLeftCenterRight

  4. The alleged scheme continued even after the FDA seized counterfeit product and issued a public warning in December 2023.

    Reported byCenterRight

  5. Both men face a maximum of 71 years in prison each if convicted on all counts.

    Reported byLeftCenterRight

  6. Roy and Ramancha are both residents of Dubai, according to court filings.

    Reported byLeft

How each side tells it

Compare views

  • the left

    1 outlet

    CBS News's headline states the indictment plainly and adds detail about discounted pricing to U.S. distributors.

    2 indicted in connection with counterfeit Ozempic scheme in Florida
    CBS NewsLeftAll left-leaning headlines

  • the center

    1 outlet

    CNBC frames the story around the DOJ announcement and links it to the broader surge in GLP-1 drug use.

    Two Indian nationals charged with smuggling counterfeit Ozempic from China: DOJ
    CNBCCenterAll center headlines

  • the right

    2 outlets

    Both right-leaning outlets use straightforward factual headlines about the indictment, with the Epoch Times emphasizing the FDA's public warning and a DOJ quote about drug safety, while the Washington Times offers a brief, minimal account.

    Justice Department indicts 2 over alleged counterfeit Ozempic sales to U.S. distributors
    The Washington TimesRightAll right-leaning headlines

The words they chose

Language to notice

Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.

Mantle found no loaded language in this coverage. Every headline and opening was checked against Mantle’s published word list, and Mantle’s AI read all 4 articles in context. Straight reporting often has none.

See for yourself

Side by side

What each side leads with and what it leaves out. Open a side to read its headlines.

From the left

1 outlet

Leads with

  • residency and citizenship details of the accused
  • discounted sales to distributors
  • regulatory oversight of the wholesale market

Leaves out

  • FDA's December 2023 public warning

Reported by other sides, not found in this side’s coverage.

See the headline from the leftHide the headlines
  • CBS NewsLeft

    2 indicted in connection with counterfeit Ozempic scheme in Florida

    Two Indian citizens are accused of smuggling counterfeit Ozempic to distributors in the U.S. at discounted prices.

    Read at CBS News (opens in a new tab)

From the center

1 outlet

Leads with

  • context of rising GLP-1/weight-loss drug demand
  • timeline of the scheme continuing after FDA seizure
  • extradition from Italy
See the headline from the centerHide the headlines
  • CNBCCenter

    Two Indian nationals charged with smuggling counterfeit Ozempic from China: DOJ

    The criminal indictment in Florida comes as the use of GLP-1 drugs such as Novo's Ozempic for weight loss has hit new highs among U.S. adults.

    Read at CNBC (opens in a new tab)

From the right

2 outlets

Leads with

  • FDA's December 2023 public warning
  • DOJ statement on pharmaceutical supply integrity
  • transnational nature of the scheme

Leaves out

  • specific penalties the defendants face
  • residency details of the accused

Reported by other sides, not found in this side’s coverage.

See the 2 headlines from the rightHide the headlines
  • The Washington TimesRight

    Justice Department indicts 2 over alleged counterfeit Ozempic sales to U.S. distributors

    A federal grand jury in the Middle District of Florida has indicted two Indian nationals on charges tied to an alleged transnational scheme to sell counterfeit Ozempic to U.S. distributors, the Justice Department announced.

    Read at The Washington Times (opens in a new tab)
  • The Epoch TimesFar Right

    Federal Grand Jury Indicts 2 Indian Nationals for Smuggling Fake Ozempic

    The Department of Justice says the smuggling continued even after the Food and Drug Administration issued a public warning in December 2023.

    Read at The Epoch Times (opens in a new tab)

Articles you open from here build My Mix, a private picture of how your reading spreads across the spectrum, kept on this device. What is My Mix?

The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.

Who reported it when

How the coverage built up

  • Left

    52 min later

    Its first report, Sep 29, 4:03 PM EDT

  • Center

    First to report

    CNBC, Sep 29, 3:11 PM EDT

  • Right

    17 hr 20 min later

    Its first report, Sep 30, 8:31 AM EDT

See the order the outlets reported inHide the order
  1. CNBCCenterSep 29, 3:11 PM EDT
  2. CBS NewsLeftSep 29, 4:03 PM EDT
  3. The Epoch TimesFar RightSep 30, 8:31 AM EDT
  4. The Washington TimesRightSep 30, 12:05 PM EDT

Times are the ones the outlets published in their own feeds, in Eastern time. Opinion is left out.

Read next

Help someone else find the truth beneath the surface

Most people see one side of a story. Share this one, so they can see how every side is telling it and decide for themselves.

Email it

Seen a mistake? Tell us what is wrong with this page